Vanguard Group
PRVA icon

Vanguard Group’s Privia Health PRVA Stock Holding History

Vanguard Group’s Portfolio PRVA Stock Details PRVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$284M Sell
11,995,970
-102,963
-0.9% -$2.51M ﹤0.01% 1359
2025
Q3 		$301M Buy
12,098,933
+607,447
+5% +$13.1M ﹤0.01% 1327
2025
Q2 		$264M Buy
11,491,486
+218,928
+2% +$5.07M ﹤0.01% 1369
2025
Q1 		$253M Sell
11,272,558
-149,152
-1% -$3.47M ﹤0.01% 1363
2024
Q4 		$223M Sell
11,421,710
-419,169
-4% -$8.31M ﹤0.01% 1494
2024
Q3 		$216M Sell
11,840,879
-92,152
-0.8% -$1.76M ﹤0.01% 1503
2024
Q2 		$207M Buy
11,933,031
+532,996
+5% +$9.44M ﹤0.01% 1474
2024
Q1 		$223M Buy
11,400,035
+121,701
+1% +$2.57M ﹤0.01% 1451
2023
Q4 		$260M Buy
11,278,334
+274,345
+2% +$6.14M 0.01% 1358
2023
Q3 		$253M Buy
11,003,989
+51,317
+0.5% +$1.3M 0.01% 1316
2023
Q2 		$286M Buy
10,952,672
+5,407,693
+98% +$143M 0.01% 1273
2023
Q1 		$153M Buy
5,544,979
+102,711
+2% +$2.71M ﹤0.01% 1594
2022
Q4 		$124M Buy
5,442,268
+617,544
+13% +$17.2M ﹤0.01% 1691
2022
Q3 		$164M Buy
4,824,724
+321,734
+7% +$11.9M ﹤0.01% 1504
2022
Q2 		$131M Buy
4,502,990
+247,109
+6% +$6.28M ﹤0.01% 1660
2022
Q1 		$114M Buy
4,255,881
+593,178
+16% +$14M ﹤0.01% 1868
2021
Q4 		$94.8M Sell
3,662,703
-464,043
-11% -$11.6M ﹤0.01% 2012
2021
Q3 		$97.2M Sell
4,126,746
-2,448,757
-37% -$85.5M ﹤0.01% 1996
2021
Q2 		$292M Buy
+6,575,503
New +$243M 0.01% 1373

Other funds holding PRVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.1B AUM 12.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Vanguard Group's PRVA Position: Q4 2025 in Review

Vanguard Group reduced its Privia Health (PRVA) stake by 0.85% in Q4 2025, selling an estimated $2.51M and leaving 11,995,970 shares worth $284M. The position accounts for ﹤0.01% of the portfolio, ranked #1359.

Vanguard Group first reported a position in PRVA in Q2 2021 and has held it in 19 quarters since. The position peaked at $301M in Q3 2025. 276 funds tracked by Wall St. Rank hold PRVA as of Q4 2025.

  • Vanguard Group held 11,995,970 shares of Privia Health worth $284M as of Q4 2025.
  • Vanguard Group sold 102,963 Privia Health shares in Q4 2025, an estimated $2.51M.
  • Privia Health made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #1359 holding.
  • Vanguard Group first reported a position in Privia Health in Q2 2021 and has held it in 19 quarters since.
  • Vanguard Group's Privia Health position peaked at $301M in Q3 2025.
  • 276 funds tracked by Wall St. Rank held Privia Health as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.